Faculty Opinions recommendation of Characterization of symptom severity and impact on four fecal incontinence phenotypes in women presenting for evaluation.

Evidence from a preliminary survey highlighted that ‘Candidatus Phytoplasma solani’, the etiological agent of bois noir (BN) disease of grapevine, infects grapevine varieties in Georgia, a country of the South Caucasus. In this study, field surveys were carried out to investigate the BN symptom severity in international and Georgian native varieties. ‘Ca. P. solani’ was detected and identified by polymerase chain reaction-based amplification and restriction fragment length polymorphism analysis of 16S ribosomal DNA, and further characterized by multiple gene typing analysis (vmp1 and stamp genes). Obtained data highlighted that the majority of Georgian grapevine varieties showed moderate and mild symptoms, whereas international cultivars exhibited severe symptoms. Molecular characterization of ‘Ca. P. solani’ from grapevine revealed the presence of 11 distinct phytoplasma types. Only one type (VmGe12/StGe7) was identical to a strain previously reported in periwinkle from Lebanon; the other ‘Ca. P. solani’ types are described here for the first time. Phylogenetic analyses of vmp1 and stamp gene concatenated nucleotide sequences showed that ‘Ca. P. solani’ strains in Georgia are associated mainly with the bindweed-related BN host system. Moreover, the fact that ‘Ca. P. solani’ strains are distributed in grapevine cultivars showing a range of symptom intensity suggests a different susceptibility of such local cultivars to BN.

Download Full-text

Best Paper Selection

Yearbook of Medical Informatics ◽

10.1055/s-0039-1677932 ◽

2019 ◽

Vol 28 (01) ◽

pp. 239-239

Keyword(s):

Symptom Severity ◽

Exploratory Study ◽

Cancer Genome ◽

Research Network ◽

Driver Genes ◽

Cancer Driver ◽

Cancer Genome Atlas ◽

Comprehensive Characterization ◽

Genome Atlas

Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortes- Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez- Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H; MC3 Working Group; Cancer Genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive characterization of cancer driver genes and mutations. Cell 2018 Apr 5;173(2):371-385.el8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029450/ Hosny A, Parmar C, Coroller TP, Grossmann P, Zeleznik R, Kumar A, Bussink J, Gillies RJ, Mak RH, Aerts HJWL. Deep learning for lung cancer prognostication: A retrospective multicohort radiomics study. PLoS Med 2018 Nov 30;15(11):e1002711 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269088/ Low CA, Dey AK, Ferreira D, Kamarck T, Sun W, Bae S, Doryab A. Estimation of symptom severity during chemotherapy from passively sensed data: Exploratory study. J Med Internet Res 2017 Dec 19;19(12):e420 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750420/ Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A, Tusquets I, Albanell J, Rodon J, Tabernero J, de Torres C, Dienstmann R, Gonzalez-Perez A, Lopez-Bigas N. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med 2018 Mar 28;10(1):25 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875005/

Download Full-text